Literature DB >> 12954633

Identification of residues and domains of Raf important for function in vivo and in vitro.

Angus Harding1, Virginia Hsu, Kerry Kornfeld, John F Hancock.   

Abstract

Random mutagenesis and genetic screens for impaired Raf function in Caenorhabditis elegans were used to identify six loss-of-function alleles of lin-45 raf that result in a substitution of a single amino acid. The mutations were classified as weak, intermediate, and strong based on phenotypic severity. We engineered these mutations into the homologous residues of vertebrate Raf-1 and analyzed the mutant proteins for their underlying biochemical defects. Surprisingly, phenotype strength did not correlate with the catalytic activity of the mutant proteins. Amino acid substitutions Val-589 and Ser-619 severely compromised Raf kinase activity, yet these mutants displayed weak phenotypes in the genetic screen. Interestingly, this is because these mutant Raf proteins efficiently activate the MAPK (mitogen-activated protein kinase) cascade in living cells, a result that may inform the analysis of knockout mice. Equally intriguing was the observation that mutant proteins with non-functional Ras-binding domains, and thereby deficient in Ras-mediated membrane recruitment, displayed only intermediate strength phenotypes. This confirms that secondary mechanisms exist to couple Ras to Raf in vivo. The strongest phenotype in the genetic screens was displayed by a S508N mutation that again did not correlate with a significant loss of kinase activity or membrane recruitment by oncogenic Ras in biochemical assays. Ser-508 lies within the Raf-1 activation loop, and mutation of this residue in Raf-1 and the equivalent Ser-615 in B-Raf revealed that this residue regulates Raf binding to MEK. Further characterization revealed that in response to activation by epidermal growth factor, the Raf-S508N mutant protein displayed both reduced catalytic activity and aberrant activation kinetics: characteristics that may explain the C. elegans phenotype.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 12954633     DOI: 10.1074/jbc.M303106200

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  8 in total

Review 1.  Ras nanoclusters: combining digital and analog signaling.

Authors:  Angus Harding; John F Hancock
Journal:  Cell Cycle       Date:  2007-10-26       Impact factor: 4.534

2.  Activation of the MAPK module from different spatial locations generates distinct system outputs.

Authors:  Kerry Inder; Angus Harding; Sarah J Plowman; Mark R Philips; Robert G Parton; John F Hancock
Journal:  Mol Biol Cell       Date:  2008-09-10       Impact factor: 4.138

Review 3.  Plasma membrane regulates Ras signaling networks.

Authors:  Tanmay Sanjeev Chavan; Serena Muratcioglu; Richard Marszalek; Hyunbum Jang; Ozlem Keskin; Attila Gursoy; Ruth Nussinov; Vadim Gaponenko
Journal:  Cell Logist       Date:  2016-02-18

4.  Raf family kinases: old dogs have learned new tricks.

Authors:  David Matallanas; Marc Birtwistle; David Romano; Armin Zebisch; Jens Rauch; Alexander von Kriegsheim; Walter Kolch
Journal:  Genes Cancer       Date:  2011-03

5.  MEK1 activation by PAK: a novel mechanism.

Authors:  Electa R Park; Scott T Eblen; Andrew D Catling
Journal:  Cell Signal       Date:  2007-01-24       Impact factor: 4.315

6.  Genetic and functional characterization of putative Ras/Raf interaction inhibitors in C. elegans and mammalian cells.

Authors:  Vanessa González-Pérez; David J Reiner; Jamie K Alan; Cicely Mitchell; Lloyd J Edwards; Vladimir Khazak; Channing J Der; Adrienne D Cox
Journal:  J Mol Signal       Date:  2010-02-23

Review 7.  Using plasma membrane nanoclusters to build better signaling circuits.

Authors:  Angus S Harding; John F Hancock
Journal:  Trends Cell Biol       Date:  2008-07-10       Impact factor: 20.808

8.  Fendiline inhibits K-Ras plasma membrane localization and blocks K-Ras signal transmission.

Authors:  Dharini van der Hoeven; Kwang-jin Cho; Xiaoping Ma; Sravanthi Chigurupati; Robert G Parton; John F Hancock
Journal:  Mol Cell Biol       Date:  2012-11-05       Impact factor: 4.272

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.